Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Consolidated Net Profit

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹9.49 Cr₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr

What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?

The latest Consolidated Net Profit ratio of MEDICAMEN BIOTECH is ₹9.49 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹9.49 Cr
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr

How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹9.49 Cr
-35.54
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr -

Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹490.4 Cr -2.8% -3.9% -25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹107,100.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -1.4% -3.8% -1.3% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.8%

-3.9%

-25.7%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses